Digital Pharma’s new gatekeeper: AI’s rising role The AI bouncer guarding the door of healthcare information isn’t going anywhere and isn’t changing its standards.
R&D Reimagining biopharma: How AI is reshaping discovery, develo... No longer confined to experimental pilots, AI is becoming a catalyst for change across the entire biopharma value chain - but there are challenges.
Digital Sponsored Precision medicine meets machine learning: AI and oncology b... A close examination of the current and future role of AI in biomarker discovery and the challenges that developers face in leveraging it.
Digital Sponsored What does it mean to have an AI-first mindset in pharma? The importance of AI in pharma and life sciences cannot be overstated.
R&D The value of unstructured data for drug companies Advancements in medical AI now allow pharmaceutical companies to leverage unstructured clinical data at scale.
Digital Implementing generative AI: A guide for commercial life scie... In a market saturated with articles highlighting the potential of generative AI, it’s crucial to also understand its limitations.
Oncology ESMO26: Lowering toxicity, extending lives, with Syncromune As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
